The Latest Psychedelics Articles from Streetwise Reports

Trial of Psilocybin Therapeutic in Treatment Resistant Depression Yields Positive Topline Results

Research Report
"We believe this data begins to form the basis of an approvable program for Compass Pathways' COMP360" in this indication, noted a BTIG report. read more >

US DEA OKs Use of Psychedelics by This Mental Health Network

Clinics that deliver novel psychiatric treatment and host clinical trials of psychedelic medicine have positioned Novamind for breakthroughs in mental health treatment. read more >

Psychedelic Drug Trials Accelerate as Decriminalization Spreads, Investment Expands

Contributed Research
McAlinden Research Partners estimates it may be only a matter of time before psychedelics become part of a biotech boom. read more >

Pharma Company Working to Unlock Psychedelic Drug's Potential for Stroke Recovery

Algernon Pharmaceuticals CEO Christopher J. Moreau and Dr. David Nutt, the company's research stroke consultant, discuss Algernon's upcoming Phase 1 study of DMT for stroke. read more >
Showing Results: 1 to 4 of 4

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts